News

A View From the Biosynthetic Bridge

By: Soft Secrets, July 20, 2017

Regulations in the US make cannabis research highly challenging. Could biosynthetic approaches to cannabinoid production prompt regulators to rethink?

From a US perspective, cannabinoid-based drug development and research has been particularly difficult because of the designation of the plant. Cannabis, including its cannabinoids, are classified as “Schedule I” drugs, which means they are defined as having “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacking “accepted safety for use […] under medical supervision.” Researchers, therefore, need to jump through a number of regulatory hoops to carry out cannabinoid research. It’s interesting to contrast the US situation with what goes on in other countries, specifically in Israel, Canada and the UK, which is where most of the breakthroughs are taking place.

In the US, a few states have reclassified and legalized cannabis. For example, Colorado, legalized the recreational use of cannabis in 2012 for individuals over the age of 21. A number of Colorado residents suffering from certain medical conditions can also access cannabis from dispensaries that offer a range of cannabis strains with different qualities. In states where cannabis is legal, it is easier to conduct research, but there are limits. When Teewinot Life Sciences first started, we decided to focus on the biosynthetic production of pharma-grade cannabinoids but it was clear that we would quickly exceed what was legal in Colorado and elsewhere in the US. Today, we are headquartered in Tampa, Florida (which implemented the Florida Medical Marijuana Legalization Initiative in 2016). We conduct our internal research and development in Canada under license from Health Canada, and all our existing and planned intellectual property are housed by our subsidiary in Ireland. In fact, a number of US companies have uprooted and moved overseas to facilitate their cannabinoid research efforts.

 SOURCE

 

Share this article Linkedin Pinterest

Read more

News

STRAIN special 2019 (3)

By: Soft Secrets, April 18, 2019

Table of contents 1. Ocean Grown Cookies 2. OGKZ Humboldt 3. Panama Aceseeds 4. Purplediol Autoflowering CBD Eliteseeds 5. Red Mandarine F1 Fast Version®(SWS79)...

— Read More
Grow

The Foliage Growth Stage

By: Thomas Valentine, April 1, 2019

Everyone likes to see big, bushy marijuana plants. But how do you get the thick, bright green foliage you see in pictures? Well, read...

— Read More
Grow

Caring For Your Seedlings

By: Soft Secrets, March 29, 2019

So you’ve sprouted your seeds and are looking forward to seeing your first crop flourish. Whether you have 4 plants or 400 plants, the...

— Read More
News

STRAIN special 2019 (1)

By: Soft Secrets, March 27, 2019

Table of contents 1. Atomic Purple El Nirvana 2. Auto Lemon Zkittle Dutch Passion 3. Auto Medikit Buddha Seeds 4. Blueberry Cookies Dinafem Seeds...

— Read More
SoftSecrets nu ook online

Soft Secrets now also available online

High-profile interviews and current news. Items that strike you and images to inspire you. But also sections on beauty, fashion, food, TV, music, art and film.

All magazines
x

We use cookies to give you the best possible online experience. By agreement you allow us to use cookies as indicated in our cookies policy.